| Sanofi-Aventis (Suisse) SA - Lasix 250 mg, solution pour perfusion |
| 36442 | | 01 | | Lasix 250 mg | | solution pour perfusion | | C03CA01 | | Furosemide | | 04.08.1971 | | |
|
| Composition |
| furosemidum 250 mg ut furosemidum natricum, mannitolum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 25 ml corresp. natrium 19.1 mg. |
| Packungsbestandteile |
| Infusion solution | | | | | | Active Agent | Dose |
|---|
| Furosemide | 250mg / 25ml |
| | | | Inactive agents |
|---|
| Mannitol | | Sodium Hydroxide |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 6 ampoule(s) | PR | PR | B | | No |
|
